|

BIOGEN INC (BIIB)

US09062X1037 - Common Stock

239.29  +0.17 (+0.07%)

After market: 239.29 0 (0%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to BIIB. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 329.95. This target is 37.89% above the current price.
BIIB was analyzed by 41 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about BIIB.
In the previous month the buy percentage consensus was at a similar level.
BIIB was analyzed by 41 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 239.29241.39321.30329.95525.00 - 0.88% 34.27% 37.89% 119.40%
Up and Down Grades
Date Firm Action Rating
2023-12-07 Raymond James Upgrade Market Perform -> Outperform
2023-11-10 Morgan Stanley Maintains Overweight -> Overweight
2023-11-09 BMO Capital Maintains Outperform -> Outperform
2023-11-09 RBC Capital Maintains Outperform -> Outperform
2023-11-09 Wedbush Maintains Neutral -> Neutral
2023-11-09 Wells Fargo Maintains Overweight -> Overweight
2023-10-26 Needham Reiterate Buy -> Buy
2023-10-26 Wedbush Maintains Neutral -> Neutral
2023-10-11 Morgan Stanley Maintains Overweight -> Overweight
2023-09-06 HSBC Initiate Buy
2023-09-05 Morgan Stanley Maintains Overweight -> Overweight
2023-08-29 RBC Capital Maintains Outperform -> Outperform
2023-08-14 Mizuho Maintains Buy -> Buy
2023-08-08 Atlantic Equities Maintains Neutral -> Neutral
2023-08-08 BMO Capital Maintains Outperform -> Outperform
2023-08-08 Needham Maintains Buy -> Buy
2023-08-08 Barclays Maintains Equal-Weight -> Equal-Weight
2023-08-08 Truist Securities Maintains Buy -> Buy
2023-08-07 Oppenheimer Maintains Outperform -> Outperform
2023-08-07 RBC Capital Maintains Outperform -> Outperform
2023-08-07 Wells Fargo Maintains Overweight -> Overweight
2023-07-31 Needham Reiterate Buy -> Buy
2023-07-31 RBC Capital Maintains Outperform -> Outperform
2023-07-27 ScotiaBank Initiate Sector Outperform
2023-07-26 BMO Capital Maintains Outperform -> Outperform
2023-07-26 Needham Maintains Buy -> Buy
2023-07-26 RBC Capital Maintains Outperform -> Outperform
2023-07-26 Wedbush Maintains Neutral -> Neutral
2023-07-26 Morgan Stanley Maintains Overweight -> Overweight
2023-07-26 HC Wainwright & Co. Reiterate Buy -> Buy